ScholarWorks@Korea University College of Medicine: Kim, Nam Hoon

Detailed Information

Kim, Nam Hoon (김남훈)

Anam Hospital (Department of Endocrinology and Metabolism, Anam Hospital)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Diabetes mellitus:20||type 2:13||Type 2 diabetes:8||Metabolic syndrome:8||Obesity:5||Sarcopenia:4||Cardiovascular diseases:4||variability:4||Diabetes complications:3||metabolic syndrome:3||Body composition:3||mortality:3||diabetes mellitus:3||Glycemic control:3||Dipeptidylpeptidase IV inhibitors:3||Diabetes mellitus, type 2:2||older people:2||osteoporosis:2||Cardiovascular disease:2||nonalcoholic fatty liver disease:2||dementia:2||Allcause mortality:2||Osteoporosis:2||Glycemic variability:2||Life style:2||Kidney failure, chronic:2||Diabetic nephropathies:2||Fasting plasma glucose:2||Diabetic retinopathy:2||Cohort studies:2||Sodiumglucose transporter 2 inhibitors:2||Heart failure:2||Anthropometry:2||stroke:2||Fenofibrate:2||heart failure:2||Practice guideline:2||Glucose:2||Dipeptidyl peptidase4 inhibitors:2||brain atrophy:2||Atherosclerosis:2||Hypothyroidism:2||Systematic review:2||COVID19:2||insulin resistance:2||Thyroid neoplasms:2||Albuminuria:2||Type 2 diabetes mellitus:2||Nonalcoholic fatty liver disease:2||cardiovascular mortality:2||Elderly:1||Empagliflozin:1||Endstage renal disease:1||Epidemiology:1||Ezetimibe:1||Fasting blood glucose:1||Fasting plasma glucose variability:1||Fatigue:1||Fatigue scale:1||Fitbit:1||Fitness trackers:1||Fulminant:1||Gastrectomy:1||Gastric cancer:1||Glomerular filtration rate:1||Glucagonlike peptide1 receptor agonist:1||Glucocorticoids:1||Glucose tolerance test:1||Glycaemic variability:1||Glycated hemoglobin A:1||Graves' disease:1||Gray matter:1||HMGCoA reductase inhibitor:1||Hearing loss:1||Heart disease risk factors:1||Hemodynamics:1||Hospitalization:1||HydroxymethylglutarylCoA reductase inhibitors:1||HydroxymethylglutarylCoA reductase inhibitors:1||Hyperparathyroidism:1||Hypertension:1||Hypoglycemic agents:1||Insulin resistance:1||Insulin therapy:1||Iodine:1||Jet lag syndrome:1||Korea:1||Korea National Health and Nutrition Examination Survey VI:1||Korean National Health Insurance Corporation:1||Lcarnitine:1||LDL:1||Lifestyle modification:1||Lipid metabolism:1||Lipids:1||Lipoprotein lipase:1||Low income:1||Low skeletal muscle mass:1||Lowdensity lipoprotein cholesterol:1||Malignant pleural effusion:1||Menopause:1||Metaanalysis:1||Metabolic health:1||Metabolite profiling:1||Metrnl:1||Microalbuminuria:1||Midlife:1||Mortality:1||Muscle:1||Muscle strength:1||NMR:1||Network metaanalysis:1||North Korea:1||North Korean refugees:1||Omega3 fatty acids:1||Osteoporotic fractures:1||PPAR alpha:1||Papillary thyroid microcarcinoma:1||Parathyroid neoplasms:1||Parkinson's disease:1||Pericardial effusion:1||Peripheral artery disease:1||Peroxisome proliferatoractivated receptors:1||Phosphodiesterase inhibitor:1||Physician and patient behaviors:1||Prediabetic state:1||Prediction:1||Pregnancy outcome:1||Prevalence:1||Product surveillance:1||Progression:1||REPUBLIC OF KOREA:1||Randomised trial:1||Renal function:1||Renal insufficiency:1||Reninangiotensin system:1||Republic of Korea:1||Respiration:1||Rhabdomyolysis:1||Risk factors:1||Rosuvastatin calcium:1||Rubus occidentalis:1||Sarcopenic obesity:1||Sclerostin:1||Sestrin2:1||Skeletal muscle:1||Sleep:1||Sleep deprivation:1||Sleep duration:1||Sodium glucose transporter 2 inhibitors:1||Sodiumglucose cotransporter 2 inhibitor:1||Statin:1||Statin duration:1||Statin intensity:1||Statins:1||Stroke:1||Sulfonylurea:1||TNP470:1||The Korean National Health Insurance Corporation:1||Therapeutics:1||Thiazolidinediones:1||Thyroid:1||Thyroid hormones:1||Thyroidstimulating hormone:1||Treatment adherence and compliance:1||Triglycerides:1||Tumor recurrence:1||Type 1 diabetes:1||Type2 diabetes mellitus:1||Variability:1||Vascular adhesion molecules:1||Visittovisit:1||Vitamin D:1||Waisttohip ratio:1||Weight gain:1||Wessely and Powell score:1||Wnt pathway:1||Young adult:1||abdominal:1||anthropometric index:1||antithyroid drug:1||artificial:1||atherosclerosis:1||beta cell function:1||black raspberry:1||body composition:1||body weight:1||bone density:1||cachexia:1||calcium supplementation:1||cardiac risk factors and prevention:1||cardiovascular disease:1||cardiovascular disease (CVD):1||central obesity:1||chronic kidney diseases:1||clinical trials:1||cognition:1||cognitive decline:1||cohort study:1||combination:1||crosssectional study:1||cytarabine:1||db/db mice:1||democratic people's republic of korea:1||depression:1||digital health intervention:1||endstage kidney disease:1||epidemiology:1||fatty liver disease:1||fetuinA:1||fibroblast growth factor 1:1||fracture:1||gammaglutamyltransferase:1||gastric emptying:1||glucose intolerance:1||glucose regulation:1||glucose tolerance:1||glucose variability:1||gray matter:1||gutbrain axis:1||health:1||health disparity:1||hepatic gluconeogenesis:1||hepatic steatosis index:1||hyperglycaemia:1||hyperthyroidism:1||hypertriglyceridaemia:1||hypothalamus:1||insulin secretion:1||insulin sensitivity:1||lacteal:1||liver steatosis:1||low muscle mass:1||lymphatic endothelial cell:1||malabsorption:1||melatonin:1||metabolic diseases:1||metabolic dysfunction:1||metabolic risk management:1||metformin:1||myocardial infarction:1||night blood pressure:1||nonobese:1||obesity:1||obstructive sleep apnea:1||occupational health:1||physical activity intervention:1||postmarketing:1||prediabetes:1||radioactive iodine treatment (RAI treatment):1||radioiodine ablation:1||refugee:1||retrospective cohort study:1||sarcopenia:1||short sleep duration:1||skeletal:1||skeletal muscle mass:1||sleep disordered breathing:1||small intestine:1||socioeconomic status:1||step counts:1||therapeutics:1||total cholesterol:1||triglycerides:1||type 2 diabetes:1||type 2 diabetes mellitus:1||vascular dementia:1||visceral obesity:1||vitamin D:1||wearable activity tracker:1||weight loss:1||단백뇨:1||대사증후군:1||유병률:1||Active surveillance:1||제2형 당뇨병:1||Adipose tissue vasculature:1||Adverse clinical outcome:1||Alzheimer disease:1||Alzheimer's dementia:1||Alzheimer's disease:1||Angiogenesis:1||Angiopoietinlike protein 3:1||Angiotensin receptor antagonists:1||Angiotensinconverting enzyme inhibitors:1||Anthropometric index:1||Apolipoprotein CIII:1||Arterial stiffness:1||BRAF V600E mutation:1||Blood glucose:1||Blood glucose selfmonitoring:1||Blood pressure:1||Body fat composition:1||Body mass index:1||Body temperature:1||Bone muscle interaction:1||Brain atrophy:1||Brown tumor:1||Calcium:1||Caloric restriction:1||Cardiocerebrovascular disease:1||Cardiometabolic risk factors:1||Cardiovascular mortality:1||Cardiovascular risk:1||Casecontrol studies:1||Cholesterol:1||Cilostazol:1||Circadian clocks:1||Circadian rhythm:1||Cluster analysis:1||Community networks:1||Dementia:1||Dementia, vascular:1||Diabetes:1||Diabetes management among older patients:1||Diabetes mellitus Glucose variability:1||Diabetes, gestational:1||Diabetic kidney disease:1||Diagnosis:1||Diet:1||Drug therapy:1||Durability:1||Dyslipidaemias:1||Dyslipidemias:1||ER stress:1||

STATISTICS: Total View :12,791,651; Today View :507

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE